INTERWEST VENTURE MANAGEMENT CO - APPLIED GENETIC TECHNOL CORP ownership

APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 54 filers reported holding APPLIED GENETIC TECHNOL CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
INTERWEST VENTURE MANAGEMENT CO ownership history of APPLIED GENETIC TECHNOL CORP
ValueSharesWeighting
Q3 2022$381,000
-64.8%
1,404,5150.0%1.17%
-41.6%
Q2 2022$1,081,000
-28.1%
1,404,5150.0%2.01%
+250.2%
Q1 2022$1,503,000
-43.7%
1,404,5150.0%0.57%
-63.6%
Q4 2021$2,669,000
-36.9%
1,404,5150.0%1.58%
-9.9%
Q3 2021$4,228,000
-23.0%
1,404,5150.0%1.75%
+1.0%
Q2 2021$5,492,000
-22.9%
1,404,5150.0%1.73%
-7.5%
Q1 2021$7,121,000
+24.0%
1,404,5150.0%1.87%
+161.2%
Q4 2020$5,744,000
-18.8%
1,404,515
-3.5%
0.72%
-64.9%
Q3 2020$7,075,000
-12.3%
1,455,9040.0%2.04%
-69.5%
Q2 2020$8,066,000
+68.9%
1,455,9040.0%6.69%
+32.6%
Q1 2020$4,776,000
-27.4%
1,455,9040.0%5.04%
+77.8%
Q4 2019$6,581,000
+8.7%
1,455,9040.0%2.84%
+22.1%
Q3 2019$6,057,000
+9.8%
1,455,9040.0%2.32%
+30.4%
Q2 2019$5,517,000
-9.6%
1,455,9040.0%1.78%
-68.2%
Q1 2019$6,100,000
+68.3%
1,455,9040.0%5.60%
+10.1%
Q4 2018$3,625,000
-65.9%
1,455,9040.0%5.09%
-1.9%
Q3 2018$10,628,000
+97.3%
1,455,9040.0%5.19%
+128.1%
Q2 2018$5,387,000
-3.9%
1,455,9040.0%2.28%
-3.6%
Q1 2018$5,605,000
+6.9%
1,455,9040.0%2.36%
+31.8%
Q4 2017$5,241,000
-8.9%
1,455,9040.0%1.79%
+19.7%
Q3 2017$5,751,000
-22.5%
1,455,9040.0%1.50%
-14.8%
Q2 2017$7,425,000
-25.9%
1,455,904
+0.3%
1.76%
-17.5%
Q1 2017$10,021,000
-26.2%
1,452,2160.0%2.13%
-34.2%
Q4 2016$13,579,0001,452,2163.24%
Other shareholders
APPLIED GENETIC TECHNOL CORP shareholders Q1 2018
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 1,455,904$7,075,0002.04%
DAFNA Capital Management LLC 1,095,139$5,322,0001.73%
Portolan Capital Management 1,301,075$6,323,0000.72%
Sofinnova Investments, Inc. 825,071$4,010,0000.30%
Ikarian Capital, LLC 545,884$2,654,0000.19%
683 Capital Management, LLC 364,299$1,770,0000.13%
Gyon Technologies Capital Management, LP 18,653$91,0000.07%
ALTRINSIC GLOBAL ADVISORS LLC 336,900$1,637,0000.07%
HighVista Strategies LLC 15,200$74,0000.05%
PURA VIDA INVESTMENTS, LLC 176,411$857,0000.04%
View complete list of APPLIED GENETIC TECHNOL CORP shareholders